Millennial in CDMX this is what you should know about the Russian vaccine – El Financiero

Beyond August 2020, Russia planned to start international clinical trials of his vaccine Sputnik V against the coronavirus, whose use was approved rapidly in that country.

Since the beginning of the work, tests and trials around this vaccine, the country led by Vladimir Putin, faced criticism for its rush to register and administer this injection.

This Friday, the Government of Mexico City reported that from next week universal vaccination will begin for people 30 years of age and older and precisely Sputnik V will be applied in:

Azcapotzalco, Álvaro Obregón, Benito Juárez, Coyoacán, Gustavo A. Madero, Miguel Hidalgo, Tláhuac and Venustiano Carranza.

Next, we tell you the unmissable facts about the Russian vaccine:

  • Sputnik V it was the first COVID-19 vaccine registered for use in the world.
  • The Gamaleya Institute of Moscow and the Ministry of Defense were in charge of developing the injection.
  • According to the results of the penultimate analysis around inoculation, the vaccine surprised the scientific community and humanity by turning out to be much better than previously believed, by throwing a 97.6 percent efficiency.
  • A study published on July 9 points out that the first dose of Sputnik V results in a 94 percent seroconversion rate, while the second dose greatly increases antibody titers and neutralizing capacity.
  • Russian scientists used two different types of adenoviral vectors (rAd26 and rAd5) for the first and second doses of the vaccine, reinforcing its immunizing effect.
  • Thus, the vaccine is composed of two vectors against coronavirus.
  • It consists of two doses, with a separation, which in the first instance was said to be 21 days between each application, but later, Russian health authorities reported that it could be of up to 180 days with the same level of effectiveness.
  • Immunity is nine months, according to the Gamaleya National Center. “The level of antibodies in people who were vaccinated is, on average, higher than in those who have been sick.”
  • Sputnik V induced a antibody response in all participants in early trials, and no serious adverse effects were found.
  • The Phase 3 of clinical trials of the vaccine began in September 2020 with the application of the dose to thousands of volunteers.
  • Foreign Minister Marcelo Ebrard indicated that a protocol of thousands of mexican volunteers to test the Russian vaccine, as part of Phase 3.
  • On September 9, the first agreement for the supply of 32 million doses of the Russian vaccine for Mexico was announced.
  • In that month the first scientific doubts about the results of the initial phase of the vaccine that was published in the medical journal The Lancet, in which it was noted that some of the findings seemed unlikely.
  • Alexander Gintsburg, director of the Gamaleya Center, stated in October 2020 that this vaccine was well received by 85 percent of people who received a dose, with no side effects.
  • That month, the green light was given to testing Sputnik V in those over 60 years of age.
  • On December 2020 started mass vaccination in Russia.
  • Argentina it was the first country outside the former USSR to approve it. Mexico He did the same in February of this year, and in this same month the first batch arrived in the country.
  • From those dates, Sputnik V became the ‘favorite vaccine’ to combat the COVID-19 pandemic around the world.
  • On July 5, 2021, Mexico reported that it produced the first test batch Sputnik V vaccine; becoming the first country in North America to do so.
  • Sputnik V refers to the launch into space of the first artificial satellite in history, carried out by the Soviet Union in 1957.
See also  Vaccine, 6,000 people refuse it in Aosta Valley - Aosta Valley


Leave a Comment